PRIMO Software Licensing
ID: FDA-75F40124Q00495Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Other Computer Related Services (541519)

PSC

IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE) (7A21)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/2583afbdc0b94da48da16b51fd927e0e/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.

    Point(s) of Contact
    Roosevelt Walker
    roosevelt.walker@fda.hhs.gov
    Files
    Title
    Posted
    FDA_75F40124Q00495_Amend 0001.pdf
    The document is an amendment to a Request for Quote (RFQ) for PRIMO Software Licensing and Maintenance Support Services issued by the FDA. The RFQ is aimed at obtaining 21 licenses for PRIMO pharmacovigilance software over a base year and two option years, ensuring continuous operation of the FDA's CFSAN CAEMS system. The submission deadline for quotes is August 26, 2024. Key requirements include delivery of software licenses within five business days post-award, a kickoff meeting, and subsequent provision of user account access and monthly usage reports. The contract will be firm-fixed-price, emphasizing the importance of compliance with technical specifications and accessibility standards. Additionally, the solicitation highlights the evaluation criteria based on technical capability and pricing, mandates electronic invoice submission through the U.S. Department of Treasury’s Invoice Processing Platform, and emphasizes protections for sensitive information. The RFQ reflects the FDA's commitment to utilizing small businesses for procurement, ensuring compliance with federal regulations throughout the process.
    FDA_75F40124Q00495.pdf
    The document outlines a Request for Quote (RFQ) for PRIMO Software Licensing and Maintenance Support Services issued by the FDA (Solicitation Number FDA-SOL-75F40124Q00495). Scheduled for response by August 26, 2024, it is designated as a total Small Business Set Aside, with a firm fixed price purchase order anticipated. The contractor is required to provide 21 PRIMO software licenses for one base year (September 29, 2024, to September 28, 2025) and two option years, ensuring continuous usage of the CFSAN CAEMS system. Key deliverables include a kickoff meeting, user account information, and monthly usage reports. The solicitation stipulates that contractors must be authorized resellers or service agents and provides specific instructions regarding pricing, invoicing through the Treasury's IPP system, and compliance with security requirements for sensitive information. Evaluation criteria will focus on technical capability and price, emphasizing adherence to federal acquisition regulations and accessibility standards. This RFQ serves to enhance the FDA's software capability while ensuring compliance with regulations and promoting small business participation.
    Lifecycle
    Title
    Type
    PRIMO Software Licensing
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Access to Outpatient Longitudinal Drug Utilization Data
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide access to outpatient longitudinal drug utilization data through a Sources Sought notice. The primary objective is to acquire existing, HIPAA-compliant data resources that will enhance drug safety evaluations, support post-market surveillance, and inform regulatory decisions, rather than developing new databases. This initiative is crucial for monitoring medication utilization trends, particularly in areas such as opioid surveillance, and aims to improve public health outcomes through rigorous analyses of drug safety data. Interested firms must submit their responses by January 23, 2025, including their business size status and DUNS number, and can direct inquiries to Telisha Wilson at telisha.wilson@fda.hhs.gov.
    Milliflex Rapid 2.0
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking responses for a Sources Sought Notice regarding the acquisition of the Milliflex Rapid 2.0 microbial detection system. This procurement aims to enhance quality control testing for bioburden contamination in pharmaceutical products, necessitating a system that is compatible with the existing Milliflex Oasis filtration pump currently in use. The initiative is critical for ensuring compliance with quality control standards in pharmaceutical manufacturing, thereby bolstering the FDA's capabilities in evaluating rapid microbial detection methods. Interested vendors must submit their responses by January 30, 2024, at 12:00 PM ET, directed to Contract Specialist Iris Johnson at Iris.Johnson1@fda.hhs.gov and Contracting Officer Maria Finan at Linda.Finan@fda.hhs.gov.
    FDA Move and Labor Services Recompete
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified certified 8(a) small business firms to provide Move and Labor Services under an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The primary objective is to assist over 14,000 personnel in the National Capital Region with various moving activities, including specialized laboratory and IT relocations, document destruction, and warehouse management. This initiative is crucial for maintaining operational efficiency and secure handling of sensitive materials within the FDA. Interested firms must submit their responses by January 23, 2025, to Sheneil Green at Sheneil.Green@fda.hhs.gov, with further details outlined in the attached Statement of Work.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY25 Broad Agency Announcement (BAA) aimed at advancing regulatory science and innovation. This opportunity invites organizations, particularly small businesses, to submit research and development proposals that address critical areas such as alternative drug development methods, advanced manufacturing technologies, and predictive toxicology, with a strong emphasis on including diverse populations in research. Proposals must be submitted by February 24, 2025, and will undergo a two-tier evaluation process, with the potential for multiple contracts awarded based on proposal quality and funding availability. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    Real-World Application for Innovation and Development
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking qualified small businesses to support its Real-World Application for Innovation and Development (RAPID) program, which aims to enhance regulatory processes through advanced data analytics and artificial intelligence. The primary objectives include the development and deployment of innovative prototypes, system maintenance, and the integration of advanced analytics into the regulatory framework to improve drug safety evaluations and regulatory reviews. This initiative is crucial for enabling FDA reviewers to efficiently access real-time data and analytics, particularly during public health events. Interested vendors must submit a capability statement by February 11, 2025, detailing their qualifications in relevant areas such as AI and cloud technologies, and can contact Noah Padilla at Noah.Padilla@fda.hhs.gov for further information.
    NOTICE OF INTENT TO SOLE SOURCE - QUADRUPOLE-ORBITRAP HIGH RESOLUTION MASS SPECTROMETER WITH LIQUID CHROMATOGRAPH
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) intends to award a sole-source contract for a benchtop quadrupole-Orbitrap™ high-resolution mass spectrometer (HRMS) with liquid chromatograph to Thermo Electron North America LLC. This specialized equipment is crucial for developing and validating methods to detect chemical residues and contaminants in food, including mycotoxins, pesticides, and veterinary drugs. The unique capabilities of the Thermo Electron instrument are necessary to meet the FDA's requirements for timely and accurate identification of contaminants in complex food samples, which is vital for ensuring food safety. Interested parties must submit a capability statement by January 27, 2025; however, if no viable responses are received, the contract will proceed without competition. For further inquiries, contact Erika Crawford at erika.crawford@fda.hhs.gov or call 301-796-0298.
    Solicitation: Tobacco Retailer Inspections - 75F40125R00018
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for the Tobacco Retailer Inspections contract (75F40125R00018), aimed at conducting compliance check inspections across multiple regions in the United States. The primary objective of this procurement is to ensure adherence to federal laws regarding the sale and advertising of tobacco products, particularly focusing on preventing youth access to these products. This contract will involve the award of multiple Indefinite Delivery/Indefinite Quantity (IDIQ) contracts, with a total contract period of five years, and will require contractors to employ commissioned inspectors and underage purchasers for effective inspections. Interested parties must submit their proposals by February 4, 2025, at 2:00 PM EST, and can direct inquiries to Janice Heard at janice.heard@fda.hhs.gov or Brandon Rafus at brandon.rafus@fda.hhs.gov.
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    RENEWAL OF SOFTWARE LICENSE, MAINTENANCE AND SUPPORT FOR GENEDATA ANALYST (AMBIS 2253271)
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract for the renewal of the Genedata Analyst software license, along with maintenance and support services. This procurement is essential for the ongoing bioinformatics and statistical analysis of large ‘multi-omics’ datasets, which are critical for understanding immune responses in human samples during influenza A virus vaccination and infection studies. The software plays a vital role in the research conducted by the Viral Pathogenesis and Evolution Section, aiding in the development of novel vaccines and antiviral therapies. Interested vendors must submit capability statements via the NIH electronic Simplified Acquisition Submission System (eSASS) by 4:00 PM EST on January 31, 2025, and can contact Rita Davis at rita.davis@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further information.
    Laboratory Vacuum System Replace and Install Irvine CA FDA
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified contractors to replace and install a laboratory vacuum system at its facility in Irvine, California. The project involves the removal of an outdated vacuum pump system, which is nearly 23 years old, and the installation of a new system that meets specific technical requirements, including energy efficiency and integration with existing building automation systems. This procurement is critical for maintaining operational reliability at the FDA Irvine facility, ensuring that essential laboratory functions can continue without interruption. Interested small businesses must submit their proposals by the specified deadlines, with a mandatory site visit scheduled for January 29, 2025, to assess existing conditions. For further inquiries, potential bidders can contact Patricia Natividad at patricia.natividad@fda.hhs.gov or by phone at 301-796-8919.